Showing results (1071-1080 of 2,068) with videos related to

Sort By:
Pageof 207
Journal of Molecular Biology|June 27, 2002
The structural basis of riboflavin binding to Schizosaccharomyces pombe 6,7-dimethyl-8-ribityllumazine synthaseStefan Gerhardt, Ilka Haase, Stefan Steinbacher, et al.
Leukemia|May 1, 2013
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutationsM Meggendorfer, U Bacher, T Alpermann, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 12, 2017
Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 mMarc M Berger, Franziska Macholz, Lukas Lehmann, et al.
The Journal of Biological Chemistry|March 15, 1986
Biosynthesis of riboflavin. Enzymatic formation of 6,7-dimethyl-8-ribityllumazine from pentose phosphatesP Nielsen, G Neuberger, I Fujii, et al.
Acta Veterinaria Scandinavica|February 22, 2023
Cutaneous protothecosis in a dog successfully treated with oral itraconazole in pulse dosingVanessa Cunningham Gmyterco, Tomasz Jagielski, Gustavo Baldasso, et al.
Biomolecules|February 25, 2023
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment OutcomeTim Lakomy, Dilara Akhoundova, Henning Nilius, et al.
Case Reports in Oncology|October 30, 2024
Therapy-Related Acute Myeloid Leukemia after CAR-T Cell Therapy with Brexucabtagene Autoleucel for Mantle Cell LymphomaFrançois Volery, Yara Banz, Alexander Heini, et al.
Proteomics. Clinical Applications|June 18, 2016
Immunoproteomics of Aspergillus for the development of biomarkers and immunotherapiesOlaf Kniemeyer, Frank Ebel, Thomas Krüger, et al.
Nuclear Medicine Communications|April 4, 2003
Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and responseB Brans, K Bacher, V Vandevyver, et al.
Immunobiology|April 5, 2003
In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU)Martin Tiefenthaler, Florian Hohla, Eveline Irschick, et al.
Pageof 207